Why the study?
Can CMR T1-mapping and speckle tracking echocardiography detect early left ventricular dysfunction in patients with systemic sclerosis?
Can CMR T1-mapping and speckle tracking echocardiography detect early left ventricular dysfunction in patients with systemic sclerosis?
CMR T1-mapping and speckle tracking echocardiography can detect early subclinical myocardial involvement and diffuse interstitial fibrosis in patients with systemic sclerosis.
Answers are grounded in this paper and cite their sources.
May support early detection of subclinical myocardial changes in SSc; hypothesis-generating and requires prospective validation.
Background: Systemic sclerosis (Ssc) leads to progressive myocardial fibrosis and subsequent alteration in function. Cardiac magnetic resonance (CMR) T1-mapping and speckle tracking echocardiography (STE) are two recent modalities able to quantify diffuse fibrosis and deformation, respectively. We aimed to determine whether these methods could detect left ventricular (LV) dysfunction at an early stage of SSc, and whether there was a relationship between myocardial alteration and plasma levels of C-terminal pro-endothelin-1 (CT-proET-1). Methods: 54 consecutive SSc patients with normal conventional echocardiography and no CMR late gadolinium enhancement, and 16 healthy controls underwent CMR T1mapping and STE. CT-proET-1 was measured in 35 patients. Results: As compared with the controls, SSc patients had shorter global (354 23 ms vs. 367 23, P=0.04) and basal inferoseptal LV post-contrast T1 values (336 22 ms vs. 353 24, P=0.01). In addition, basal inferoseptal segment in SSc patients showed decreased longitudinal peak systolic strain as compared with controls (-16.3 4% vs -19.6 4%, P=0.009). T1 value correlated with parameters of longitudinal function (P<0.001). Finally, CT-proET-1 level was higher in patients with shorter T1 value (78 8 vs.52 3 pmol/L, P=0.03) and correlated with peak early diastolic strain rate (r=0.51, P=0.002) within the basal inferoseptal segment. Conclusion: CMR T1-mapping and STE can detect early abnormalities in the course of SSc, which might reflect the increase in diffuse interstitial fibrosis, and their consequences on the myocardial function.
No takes yet. Share an insight, caveat, or question.
Thuny et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: